Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...

Scientists developed an antibody treatment that reawakens the immune system to attack pancreatic tumors by blocking sugar-coated disguises cancer cells use to evade detection([1]) . Researchers also ...

Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic ...

Pancreatic cancer, one of the most brutal and deadly diseases, sees approximately 10,800 new cases annually – 30 each day, in the UK – according to Cancer Research UK.It is the ...

The total pancreatic cancer market size is expected to increase in the 7MM during the forecast period, driven by ongoing ...

A mum-of-two has been left “devastated” after her sickness and lack of appetite turned out to be pancreatic cancer.

How your back pain could be a sign of cancer - Abdominal pain or back pain could be symptoms of the UK’s fifth deadliest ...

PANCREATIC Cancer Awareness Month, which ran throughout November, closed on November 30 with renewed calls for early detection, stronger public education and greater investment in research for one of ...

Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools.

A 3D micro-Light Emitting Diode (LED) device has been developed that wraps around the pancreas like octopus tentacles, ...

The NCI grant is allowing Xu’s team to continue dissecting the interactions among Lfng, Notch3, and other key signaling pathways involved in PDAC initiation and progression. The goal is to translate ...

Antigen spreading was evaluated in a subset of Phase 2 patients to assess the ability of ELI-002 7P to broaden immune responses to personalized ...